Free Trial

Short Interest in Crescent Capital BDC, Inc. (NASDAQ:CCAP) Rises By 65.9%

Crescent Capital BDC logo with Finance background

Crescent Capital BDC, Inc. (NASDAQ:CCAP - Get Free Report) saw a large increase in short interest in April. As of April 15th, there was short interest totalling 231,300 shares, an increase of 65.9% from the March 31st total of 139,400 shares. Approximately 0.6% of the shares of the stock are sold short. Based on an average daily volume of 154,700 shares, the days-to-cover ratio is currently 1.5 days.

Institutional Trading of Crescent Capital BDC

Institutional investors have recently bought and sold shares of the company. Franklin Resources Inc. lifted its stake in shares of Crescent Capital BDC by 35.2% in the 3rd quarter. Franklin Resources Inc. now owns 256,279 shares of the company's stock valued at $4,726,000 after purchasing an additional 66,713 shares during the period. Raymond James Financial Inc. acquired a new position in Crescent Capital BDC in the fourth quarter valued at approximately $3,750,000. Redhawk Wealth Advisors Inc. bought a new position in shares of Crescent Capital BDC during the 4th quarter worth approximately $659,000. Oppenheimer & Co. Inc. acquired a new stake in shares of Crescent Capital BDC during the 4th quarter worth approximately $261,000. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Crescent Capital BDC during the 4th quarter worth approximately $661,000. Institutional investors own 49.46% of the company's stock.

Crescent Capital BDC Price Performance

Shares of CCAP traded up $0.31 during trading hours on Friday, reaching $16.01. The stock had a trading volume of 58,142 shares, compared to its average volume of 143,217. The stock has a market capitalization of $593.36 million, a PE ratio of 8.05 and a beta of 0.56. Crescent Capital BDC has a 12 month low of $13.54 and a 12 month high of $20.19. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.26 and a current ratio of 1.32. The company's 50-day moving average is $16.51 and its two-hundred day moving average is $18.24.

Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last announced its earnings results on Wednesday, February 19th. The company reported $0.55 EPS for the quarter, missing the consensus estimate of $0.56 by ($0.01). The company had revenue of $46.40 million for the quarter, compared to analyst estimates of $47.27 million. Crescent Capital BDC had a return on equity of 11.90% and a net margin of 37.32%. Research analysts expect that Crescent Capital BDC will post 2.09 EPS for the current year.

Crescent Capital BDC Dividend Announcement

The company also recently announced a dividend, which will be paid on Friday, June 13th. Investors of record on Friday, May 30th will be paid a dividend of $0.05 per share. The ex-dividend date is Friday, May 30th. Crescent Capital BDC's dividend payout ratio is presently 84.42%.

Analyst Ratings Changes

CCAP has been the topic of a number of analyst reports. Wells Fargo & Company reduced their price objective on shares of Crescent Capital BDC from $18.00 to $16.00 and set an "equal weight" rating on the stock in a research note on Monday, April 28th. Keefe, Bruyette & Woods reduced their price target on shares of Crescent Capital BDC from $20.00 to $18.50 and set an "outperform" rating on the stock in a research report on Tuesday, April 8th. One analyst has rated the stock with a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $18.50.

Get Our Latest Analysis on CCAP

About Crescent Capital BDC

(Get Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Featured Stories

Should You Invest $1,000 in Crescent Capital BDC Right Now?

Before you consider Crescent Capital BDC, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crescent Capital BDC wasn't on the list.

While Crescent Capital BDC currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

ACT FAST! Congress Is POURING Into This Stock
The Hottest AI Stock You Haven’t Bought Yet
This $13 Trillion Energy Breakthrough Will Make Millionaires

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines